Filing Details

Accession Number:
0001209191-14-006657
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-03 20:21:05
Reporting Period:
2014-01-30
Filing Date:
2014-02-03
Accepted Time:
2014-02-03 20:21:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1515673 Ultragenyx Pharmaceutical Inc. RARE Pharmaceutical Preparations (2834) 272546083
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1598426 William Aliski C/O Ultragenyx Pharmaceutical Inc.
60 Leveroni Court
Novato CA 94949
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-01-30 5,000 $21.00 36,903 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2014-01-30 17,500 $0.00 17,500 $21.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
17,500 2024-01-29 No 4 A Direct
Footnotes
  1. Purchase of shares in Issuer's directed share program in connection with the Issuer's initial public offering.
  2. The option shall vest with respect to 1/36th of the shares monthly such that the options shall be fully vested on the third anniversary of the grant date.